Acquisitions15 Jun 2025, 08:02 pm
Authum Investment Acquires 3.43% Stake in OneSource Specialty Pharma for INR 796 Crores
AI Summary
Authum Investment & Infrastructure Ltd has acquired a 3.43% stake in OneSource Specialty Pharma Limited, a public limited company based in India, for INR 796 Crores. The acquisition was part of a commercial transaction and did not require any governmental or regulatory approvals. The fair market value of the shares was INR 2,028 per share. OneSource Specialty, formerly known as Stelis Biopharma Limited, is India’s first specialty pharma pure-play Contract Development and Manufacturing Organization (CDMO), established in 2007 and headquartered in Bengaluru.
Key Highlights
- Authum Investment acquired a 3.43% stake in OneSource Specialty Pharma Limited for INR 796 Crores.
- The acquisition was part of a commercial transaction and did not require any governmental or regulatory approvals.
- The fair market value of the shares was INR 2,028 per share.
- OneSource Specialty is India’s first specialty pharma pure-play Contract Development and Manufacturing Organization (CDMO).
- The company was established in 2007 and is based in Bengaluru.